Randox
UK diagnostics company / From Wikipedia, the free encyclopedia
Randox is a Northern Irish health and toxicology company in the in vitro diagnostics industry headquartered in Crumlin, County Antrim, Northern Ireland, owned by Peter FitzGerald. The company develops diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. It develops, manufactures and markets reagents and equipment for laboratory medicine, with a distribution network of 145 countries. Randox is the biggest polymerase chain reaction testing provider in the United Kingdom and Republic of Ireland.[2][3][4] Randox received three contracts by the Department of Health and Social Care without having to compete for a tender.
Company type | Private limited company |
---|---|
Founded | 1982 |
Founder | Peter FitzGerald |
Headquarters | Crumlin, County Antrim, Northern Ireland, UK |
Number of locations | 145 countries |
Key people | Peter FitzGerald (owner) |
Revenue | £619,000,000 (2021)[1] |
£275,000,000 (2021)[1] | |
Total assets | £47,700,000 (2018) |
Website | www |
In 2020, Randox was awarded nearly £500 million by the UK government to provide private-sector COVID-19 testing at the cost of about £49 per kit.[5]